PUBLISHER: Astute Analytica | PRODUCT CODE: 1887781
PUBLISHER: Astute Analytica | PRODUCT CODE: 1887781
China myopia control lenses market is experiencing robust and sustained growth, reflecting the urgent need to address the widespread prevalence of myopia among young populations. Valued at US$ 317.10 million in 2024, the market is projected to reach a valuation of US$ 935.60 million by 2033. This represents a compound annual growth rate (CAGR) of 13.30% during the forecast period from 2025 to 2033, underscoring the rapid expansion and increasing demand for myopia control solutions in China.
Several key factors are driving this strong market trajectory. First and foremost is the alarmingly high prevalence of myopia among children and teenagers throughout the country. As myopia rates continue to climb, parents and healthcare providers are becoming increasingly proactive in seeking effective interventions to slow the progression of this vision impairment. Alongside this, significant support from both the government and consumers further fuels market growth.
China myopia control lenses market is marked by intense competition between domestic and international manufacturers, each striving to capture a larger share of this rapidly expanding sector. At the forefront of the market is EssilorLuxottica, a global leader that capitalizes on its extensive manufacturing capabilities, including a sprawling 120,000-square-meter facility in Danyang.
On the other hand, domestic players are making significant inroads by targeting different consumer segments with more affordable options. Mingyue Lens, for example, is disrupting the market by offering its "Easy Control" lenses at a price point that is much more accessible to China's burgeoning middle class. This demographic, while eager to invest in effective myopia control solutions, often finds international brands prohibitively expensive.
Core Growth Drivers
China faces exceptionally high rates of myopia, especially among children and adolescents, which is a primary factor fueling the rapid growth of the myopia control solutions market. As of 2024, the scale of this issue is staggering, with approximately 100 million young individuals estimated to require immediate vision correction and intervention. This immense volume of affected children and teenagers underscores the urgent public health challenge that myopia presents across the country. The overall prevalence of myopia among Chinese youth has surged to 51.9%, marking a significant structural shift in the nation's health landscape and signaling the widespread nature of this vision disorder.
Emerging Opportunity Trends
A defining trend transforming the China myopia control lenses market is the swift medicalization of retail optical stores. Gone are the days when these stores simply sold frames; today, retailers are expected to provide comprehensive "myopia management packages" that go beyond just the product. These packages typically combine myopia control lenses with follow-up examinations and axial length measurement services, often bundled at prices ranging from USD 550 to USD 600. This shift reflects a broader change in the market, where the emphasis is no longer just on selling a physical product but on delivering a full spectrum of clinical care and monitoring, ensuring that myopia progression is actively managed over time.
Barriers to Optimization
Despite the rapidly growing demand for myopia control lenses in China, the industry faces significant challenges that threaten to slow its momentum. One of the primary obstacles is affordability. High-performance myopia control lenses, known for their advanced technology and clinical effectiveness, come with a substantial price tag. Given that these lenses often need to be replaced every six to twelve months to maintain optimal vision correction and myopia management, the cumulative financial burden on families can be considerable. This ongoing expense places a strain on many households, leading some to reconsider their investment in premium lens brands. Industry data reveals that approximately 22% of families eventually discontinue purchasing specific high-end brands due to the prohibitive cost, highlighting affordability as a critical barrier to sustained market growth.
By Product Type, Spectacle lenses currently dominate the China myopia control lenses market, capturing a substantial 53.10% share. This dominance is largely due to their reputation as the safest and most accessible form of intervention for families dealing with childhood myopia. These lenses offer a non-invasive, convenient solution that requires minimal adjustment, making them an attractive choice for parents who want effective vision correction without the complexities associated with other treatment options. They are widely available and easy to use, making them the ideal method for managing myopia progression, especially in a market where parental trust and comfort are paramount.
By Age Group, Children represent an overwhelming majority of the revenue in the China myopia control lenses market, accounting for a striking 83.50% of the total. This dominance is fundamentally linked to the declining average age of myopia onset in urban areas, which has dropped to approximately six years old. This early onset of myopia among children creates a pressing demand for effective vision correction solutions, making this age group the primary driver of market growth. The urgency surrounding myopia control in young populations is underscored by current health statistics, which estimate that more than 100 million Chinese children and adolescents require some form of vision correction.
By Technology integration, the integration of light filtering and UV protection technology has become a defining feature of premium myopia control lenses in China, generating the highest market revenue share at 46.80%. This technology has evolved into a standard specification, particularly for student progressive lenses, reflecting a widespread adoption driven by parental concerns. Surveys indicate that many parents strongly believe that blue-light filtering capabilities help reduce digital eye strain caused by prolonged exposure to screens such as tablets and computers, which are increasingly common in children's daily lives.
By Gender, the female population represents a slightly larger share, accounting for nearly 52.80% of the total market. This dominance is closely linked to epidemiological research indicating that girls experience faster rates of axial elongation-a key factor in myopia progression-compared to boys. This biological difference significantly influences market dynamics, as it creates a heightened need for timely and effective myopia control interventions specifically tailored to female children.
By Price Tier, the premium price tier dominates revenue generation, accounting for the highest share at 49.20%. This substantial market segment highlights a clear trend among Chinese parents who prioritize clinical effectiveness and long-term vision protection for their children over the immediate cost of the lenses. Despite the relatively high price range-typically between USD 300 and USD 700 per pair-these advanced lenses remain highly sought after, reflecting a willingness among consumers to invest in premium solutions that offer superior myopia control benefits.
By Age Group
By Gender
By Product Type
By Material
By Technology integration
By Price Tier
By Sales Channel